8 results
Coverage of common antibiotics used in the hospital

For empiric coverage, first define the type of infection,
prior resistance. e.g ... ESBL, KPC, VRE. etc ... ampicillin #management ... #antibiogram #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
interrupted schedule (e.g ... interrupted schedule (e.g ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
Intern Pocket Cards - Antibiogram and Susceptibilities
VRE - MRSA - GRAM POSITIVES - GRAM NEGATIVES -
(e.g., UTI, bacteremia ... , etc.) ... #antibiotics #management ... #pharmacology
IBD Therapeutic Drug Monitoring Thresholds
 - Infliximab > 7 mcg/ml
 - Adalimumab > 8 mcg/ml
 -
Infliximab > 7 mcg ... Adalimumab > 8 mcg ... Monitoring #Thresholds #management ... #gastroenterology ... #pharmacology
Diagnosis and Management of Achalasia - ACG Guidelines

Who to suspect?
 • Patients presenting with progressive dysphagia
Diagnosis and Management ... of Achalasia - ACG ... Botulinum toxin • Pharmacologic ... Achalasia #Diagnosis #Management ... #gastroenterology
Eosinophilic Esophagitis (EoE) - Topical Corticosteroids
 • Liquid - Budesonide - 1 mg PO BID -
Fluticasone 880 mcg ... is available Gastroenterology ... Corticosteroids #management ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
other factors (e.g ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Prevention and Treatment of Pneumocystis Pneumonia (PCP) in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
count monitoring (e.g ... opportunistic #infections #HIVAIDS ... #management #pharmacology